VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

Ítems similars

• TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
  per: Papadopoulos Thomas, et al.
  Publicat: (2007-08-01)
• Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
  per: Jin Yujuan, et al.
  Publicat: (2023-05-01)
• Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
  per: Jiaping Liu, et al.
  Publicat: (2024-06-01)
• Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
  per: Kana Hashimoto, MD, et al.
  Publicat: (2024-11-01)
• Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway
  per: Cong Hou, et al.
  Publicat: (2021-08-01)